El-Hibri Fuad Blog

Posts Tagged ‘fuad

BioPort is the only FDA-licensed producer of the anthrax vaccine.

Fuad El-Hibri, chairman and CEO of Emergent BioSolutions Inc., speaks March 9 in Sage Hall. Kevin Stearns/University Photography

On March 9, MBA students taking International Political Risk Management, a course taught by Elena Iankova, a lecturer at the S.C. Johnson Graduate School of Management, heard Fuad El-Hibri, chairman and CEO of Bioport’s parent company, Emergent BioSolutions Inc., discuss the hurdles his firm faces in making and marketing its products abroad.

His guest lecture was titled “Managing International Risk in the Bio-Defense and Telecommunications Industries.”

Using his own company as an example, El-Hibri outlined six areas of risk in international business, among them export/import regulations, politics at home and abroad and financial issues. Much of his talk focused on political issues ranging from export regulations to how to deal with foreign governments.

One hurdle: when BioPort sought to export its anthrax vaccine, BioThrax, the U.S. Department of Defense claimed the vaccine was primarily of military importance and should therefore fall under International Traffic in Arms Regulations (ITAR). Under ITAR, export of the vaccine is controlled by the Department of State and a license is required for each sale. BioPort succeeded in arguing that its product was non-military in nature and therefore belonged under Export Administration Regulations (EAR). Exportation under EAR is controlled by the Department of Commerce and has far fewer restrictions.

El-Hibri seemed to take such challenges in stride. “Obviously,” he said, “the U.S. government is interested in vaccines, especially bio-defense vaccines.” It controls which countries vaccines can be exported to and may use them as a bargaining chip in its own deals with foreign ministries of defense, he commented. “They like to throw our vaccine into the mix and say, ‘Listen, if you buy one more tank or one more fighter jet … we’ll throw in 10,000 doses of anthrax vaccine,'” he said. But such giveaways create problems for companies like BioPort by reducing demand for its products in foreign countries.

Some uncontrollable variables that affect the demand for vaccines are: Politics within the foreign country, the country’s relationship with the United States, its finances, its fears about external threats and regional geopolitics, noted El-Hibri.

fuadelhibri

Mr. Fuad El-Hibri is the Chairman and Chief Executive Officer of Emergent BioSolutions Inc. (Emergent)

family, health, polo, music, telecommunications, telecom, science, technology, banking, mergers, acquisitions, management, academia

Fuad El-Hibri, chairman and chief executive officer at Emergent BioSolutions Inc., is a finalist for the Ernst & Young Entrepreneur of the Year® 2009 Award in the Greater Washington region. The awards program recognizes extraordinary innovation, financial performance and personal commitment to a businesses and its community. Emergent BioSolutions, based in Rockville, is a biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics.

Early Life

Fuad El-Hibri (born March 2, 1958) in Hildesheim, Germany[1] spent his childhood equally in Europe and the Middle East before coming to the USA to get an economics degree from Stanford and an MBA from Yale

Education

Mr.El-Hibri earned a Masters Degree in Public and Private Management from Yale University and a Bachelors Degree with Honors in Economics from Stanford University.

Early Career

Fuad El-Hibri served as president of Digicel from August 2000 to February 2005. Mr. El-Hibri served as the president of East West Resources Corporation from September 1990 to January 2004.

Mr. El-Hibri was a member of the senior management team of Speywood, LTD., in the United Kingdom. and organized and directed the management buyout of Porton Products Ltd. El-Hibri reorganized Porton, and was advisor to the senior management team involved in the oversight of operations and served as a senior associate and resident project manager at Booz Allen Hamilton and as a manager of Citicorp in New York (Mergers and Acquisitions), and in Jeddah, Saudi Arabia (Operations and Credit)…..

Fuad El-Hibri

Official photo portrait of Fuad El-Hibri
Born Fuad El-Hibri
Hildesheim, DE
Occupation Chairman of the Board of Directors and CEO of Emergent BioSolutions